A case series of suprascapular nerve block (with an historical comparator) for shoulder pain in motor neurone disease

Palliat Med. 2020 Sep;34(8):1127-1133. doi: 10.1177/0269216320929553. Epub 2020 May 29.

Abstract

Background: Shoulder pain is a distressing but under-reported and poorly managed symptom in people with motor neurone disease.

Objectives: This study aimed to assess the efficacy of suprascapular nerve block for the management of shoulder pain in patients with motor neurone disease.

Methods: A total of 27 patients with motor neurone disease and shoulder pain were offered a suprascapular nerve block. Ten of these patients had bilateral shoulder pain and both were injected, making a total of 37 shoulders. The patients were followed up for a total of 3 months, or until death. Shoulder pain was measured using the pain scale (out of 100) of the shoulder pain and disability index and compared with baseline scores and a placebo control group from an earlier study using the same methodology (ACTRN12619000353190).

Results: Following the nerve block there was a significant improvement of pain scores from baseline (58.4) at week 1 (20.8, p < 0.000), week 6 (17.6, p < 0.000) and week 12 (30.4, p = 0.001) and a significant improvement compared with the control group across each time interval.

Conclusion: Suprascapular nerve block is a safe, effective therapy for patients with chronic shoulder pain.

Keywords: Shoulder pain; case series; motor neurone disease; suprascapular nerve block.

MeSH terms

  • Humans
  • Nerve Block*
  • Pain Measurement
  • Range of Motion, Articular
  • Shoulder Pain* / drug therapy
  • Treatment Outcome

Associated data

  • ANZCTR/ACTRN12619000353190